Completed PHASE3 INTERVENTIONAL 2-arm NCT00490087

Resectoscopic Treatment of Atypical Endometrial Polyps in Fertile Women

Operational Hysteroscopy Versus Traditional Surgery: Costs and Health Benefits

Sponsor: IRCCS Burlo Garofolo

Conditions Atypical Endometrial Hyperplasia Atypical Endometrial Polyps

Interventions Levonorgestrel intrauterine device (IUD)

Updated 5 times since 2017 Last updated: Sep 1, 2011 Started: Jan 31, 1999 Primary completion: Mar 31, 2007 Completion: Mar 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Atypical Endometrial Hyperplasia and Atypical Endometrial Polyps, this trial is completed. The trial is conducted by IRCCS Burlo Garofolo and has accumulated 5 data snapshots since 1999. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jan 1999

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

IRCCS Burlo Garofolo

Data source: IRCCS Burlo Garofolo

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Trieste, Italy